Phytopharmacological evaluation of ethanol extract of Sida cordifolia L.roots

Objective:To investigate the phytochemical screening(group determination)and selected pharmacological activities(antioxidant,antimicrobial and analgesic activity)of the plant Sida cordifolia Linn(S.cordifolia).Methods:Eighty percent concentrated ethanol extract of the roots was used.To identify the chemical constituents of plant extract standard procedures were followed.In phytochemical screening the crude extract was tested for the presence of different chemical groups like reducing sugar,tannins,saponins,steroids,flavonoids,gums,alkaloids and glycosides.The antioxidant property of ethanolic extract of S.cordifolia was assessed by DPPH free radical scavenging activity.Analgesic activity of the extract was tested using the model of acetic acid induced writhing in mice.Diclofenac sodium is used as reference standard drug for the analgesic activity test Antibacterial activity of plant extract was carried out using disc diffusion method with five pathogenic bacteria comparison with kanamycin as a standard.Results:Phytochemical analysis of the ethanolic extract of the roots of S.cordifolia indicated the presence of reducing sugar,alkaloids,steroids and saponins.In DPPH scavenging assay the IC_(50)value was found to be 50 ug/mL which was not comparable to the standard ascorbic acid.The crude extract produced 44.3%inhibition of writhing at the dose of 300 mg/kg body weight which is statistically significant(P>0.001).The in vitro antimicrobial activity of the ethanol extract of the roots of S.cordifolia showed no antimicrobial activity against five types of microorganisms.The experiment was conducted only with five species of bacteria as test species,which do not at all indicate the total inactivity against micro-organisms.Condusions:The obtained results provide a support for the use of this plant in traditional medicine but further pharmacological studies are required.

Role of T cells in cancer immunotherapy:Opportunities and challenges

Immunotherapies boosting the immune system's ability to target cancer cells are promising for the treatment of various tumor types,yet clinical responses differ among patients and cancers.Recently,there has been increasing interest in novel cancer immunotherapy practices aimed at triggering T cell-mediated anti-tumor responses.Antigen-directed cytotoxicity mediated by T lymphocytes has become a central focal point in the battle against cancer utilizing the immune system.The molecular and cellular mechanisms involved in the actions of T lymphocytes have directed new therapeutic approaches in cancer immunotherapy,including checkpoint blockade,adoptive and chimeric antigen receptor(CAR)T cell therapy,and cancer vaccinology.This review addresses all the strategies targeting tumor pathogenesis,including metabolic pathways,to evaluate the clinical significance of current and future immunotherapies for patients with cancer,which are further engaged in T cell activation,differentiation,and response against tumors.